Efficacy and safety from this phase IV study were consistent with data from the Vabysmo phase III DME studies
He will join in place of Anil Arora, current President- Formulations Operations who will be superannuating in November, 2024
The partnership marks a pivotal step towards developing new therapies for combating Sickle Cell Disease
SIBUR is developing a special grade of polycarbonate compatible with radiation sterilization
Under the licensing agreement, Alkem will carry out the clinical development of “SON-080” in India with support from Sonnet and enable global and India regulatory filings
Biotin Sublingual Spray and Melatonin Sublingual Spray to help consumers tackle health issues that come with today’s fast-paced life
WCK 6777 is the only once-a-day drug in global antibiotic pipeline designed for outpatient parenteral antimicrobial therapy
The company plans to advance Ropanicant into double-blind, placebo-controlled Phase-2b clinical study in MDD patients, anticipated to start in early 2025
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
The special financing terms offered by United Imaging and structured by Medikabazaar to Krsnaa Diagnostics underscore the strategic importance of this alliance
Subscribe To Our Newsletter & Stay Updated
